eli lilly obstructive sleep apnea news

Eli Lilly Gets FDA Approval for Zepbound

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

Hosted on MSN · 15h

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

The Wall Street Journal on MSN · 13h

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and only prescription medicine for those suffering from this condition.

The Hill1h

FDA approves weight-loss drug to treat sleep apnea

On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use, approving a prescription medicine suited for adults suffering from moderate to severe obstructive sleep ...

16hon MSN

The First Sleep Apnea Drug Is Here

T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Eli Lilly Gets FDA Approval for Zepbound

Trending now

Related topics